Eating Recovery Center, The Greater Philadelphia iaedp Chapter, CHOP, and Penn Medicine host Dr. Kamryn Eddy to present on the treatment of Avoidant Restrictive Food Intake Disorder
**While I don’t have the official invitation yet (Official invitation to follow) I wanted to give you a chance to schedule accordingly as this is such a wonderful opportunity to have Dr. Kamryn Eddy of Harvard here in Phillaledphia to educate us on the treatment of ARFID.
Details
Date: September 19, 2019
Time- Sign in begins at 8:45am
Presentation from 9:30-11:30am
Location- Abramson Pediatric Research Center at CHOP 3615 Civic Center Blvd Philadelphia PA
Speaker: Dr. Kamryn Eddy
Title: Avoidant-Restrictive Food Intake Disorders: Advances in Treatment
Bio: Dr. Eddy is the Clinical and Research Program and associate professor of psychology at Harvard Medical School. She is a clinical psychologist with expertise in the delivery of evidence-based treatments for eating disorders. She is a Fellow of the Academy for Eating Disorders and a member of the Eating Disorders Research Society and her research is supported through the National Institutes of Health and private foundations. Her program of research focuses on diagnosis, treatment, and neurobiological bases of eating disorders and along with Dr. Jennifer Thomas she developed a novel psychotherapy for avoidant/restrictive food intake disorder. She is the author of Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR): Children, Adolescents and Adults and over 120 published research papers and book chapters.
Summary: Avoidant/restrictive food intake disorder (ARFID) was introduced into the diagnostic classification system in DSM-5 in 2013. While research on ARFID has proliferated in the past six years, as a field, we are still in our infancy of understanding how best to treat this heterogeneous illness. Building on a multi-disciplinary research-based conceptualization of ARFID characterized by sensory sensitivity, lack of interest in eating or food, and/or fear of aversive consequences, we developed a manualized cognitive-behavioral therapy for ARFID (CBT-AR). CBT-AR comprises 20-30 outpatient sessions which can be delivered in a family-supported or individual format to children, adolescents, and adults. This talk will describe the fundamentals of CBT-AR, introduce data supporting its efficacy, and outline next steps to guide clinical research in ARFID.
** CHOP employees - no charge to enter (there will be a charge fro CEs), iaedp members $20, all others $30.
*** CEs will be issued
An official invitation will follow this “Save the Date”
Spaces are limited to please don’t hesitate to respond and don’t miss this wonderful opportunity!
